PMID- 15614145 OWN - NLM STAT- MEDLINE DCOM- 20050131 LR - 20190713 IS - 0041-1337 (Print) IS - 0041-1337 (Linking) VI - 78 IP - 12 DP - 2004 Dec 27 TI - Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies. PG - 1729-39 AB - BACKGROUND: Human leukocyte antigen (HLA)-DR ligation mediates cell death of antigen-presenting cells (APC), including mature B cells, macrophages, and dendritic cells. This study investigates the apoptotic effects of HLA class II ligation mediated by anti-HLA antibodies on activated human vascular graft endothelial cells (ECs). METHODS: HLA class II expression was examined by flow cytometry using a panel of HLA-typed vascular ECs isolated from transplant donors and compared with that of B lymphocytes. The apoptotic effects of anti-HLA-DR monoclonal antibodies (mAbs) were investigated using viability assays, DNA content analysis, and annexin-V labeling. Intracellular signaling pathways mediated by HLA-DR ligation on ECs were examined by Western blotting. RESULTS: Even with optimal stimulation, the expression of HLA-DR on interferon (IFN)-gamma-treated ECs was quantitatively lower (3-5-fold) than that on B cells. Whereas anti-HLA-DR monomorphic mAbs induced apoptosis of B cells (approximately 22%), no significant apoptosis of IFN-gamma-activated (DR-positive) ECs ( < 5%), collected from the same donor, was observed under the same conditions. Similarly, specific polymorphic anti-HLA-DR11 or -DR16 antibodies were unable to induce EC apoptosis. Nevertheless, antibody-binding to HLA-DR on ECs is sufficient to induce intracellular signaling, as evident in the modulation of tyrosine phosphorylation and protein kinase (PK)C-alpha/beta and PKB/Akt activation. Our results suggest that HLA-DR ligation induces both common and divergent signaling events in ECs and B cells. CONCLUSION: Collectively, our data suggest that, in contrast with professional APC, graft ECs evade apoptosis mediated by HLA-DR ligation, not as a result of moderate HLA-DR expression but rather as a result of a specific signaling pathway. FAU - Le Bas-Bernardet, Stephanie AU - Le Bas-Bernardet S AD - Institut National de la Sante et de la Recherche Medicale, Unite 643 Immunointervention en Allo et Xenotransplantation, Hotel-Dieu, Nantes, France. FAU - Coupel, Stephanie AU - Coupel S FAU - Chauveau, Annabelle AU - Chauveau A FAU - Soulillou, Jean-Paul AU - Soulillou JP FAU - Charreau, Beatrice AU - Charreau B LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Transplantation JT - Transplantation JID - 0132144 RN - 0 (Antibodies, Monoclonal) RN - 0 (HLA-DR Antigens) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Isoantibodies) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Antibodies, Monoclonal/pharmacology MH - Apoptosis/*physiology MH - Arteries/cytology MH - B-Lymphocytes/drug effects/metabolism/physiology MH - Cells, Cultured MH - Endothelial Cells/drug effects/metabolism/*physiology MH - HLA-DR Antigens/*immunology MH - Histocompatibility Antigens Class II/*immunology/metabolism MH - Humans MH - Interferon-gamma/pharmacology MH - Isoantibodies/*physiology MH - Signal Transduction/physiology EDAT- 2004/12/23 09:00 MHDA- 2005/02/03 09:00 CRDT- 2004/12/23 09:00 PHST- 2004/12/23 09:00 [pubmed] PHST- 2005/02/03 09:00 [medline] PHST- 2004/12/23 09:00 [entrez] AID - 00007890-200412270-00008 [pii] AID - 10.1097/01.tp.0000147339.31581.99 [doi] PST - ppublish SO - Transplantation. 2004 Dec 27;78(12):1729-39. doi: 10.1097/01.tp.0000147339.31581.99.